Philips supports Tampere Heart Hospital in Finland to decarbonize its clinical operations
2023年10月19日 - 6:00PM
Philips supports Tampere Heart Hospital in Finland to decarbonize
its clinical operations
October 19, 2023
Sustainability roadmap addresses opportunities to reduce carbon
emissions in patient throughput, technology use, and use of
consumables
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced the completion of a comprehensive hospital-wide analysis
of Tampere Heart Hospital – Tampere University Hospital’s (Finland)
environmental sustainability, including a deep assessment of the
interventional cardiology space and evaluation of its carbon
footprint. The results of the analysis have been translated into a
joint action plan that will help Heart Hospital accelerate its
decarbonization efforts in line with Finland’s world-leading
commitment to reach net zero emissions by 2035.
“Sustainability is an integral part of Tampere Heart Hospital
strategy. We are aware that hospitals generate a significant amount
of waste daily and consume a lot of energy. We want to contribute
to the development of environmental responsibility in healthcare,”
said Pasi Lehto CEO and Chief Medical Officer at Heart
Hospital.
“We want to ascertain where we are now and how we can further
accelerate our transition towards net zero,” said Aki Haukilahti,
CFO at Tampere Heart Hospital. “Our long-standing relationship with
Philips and their industry leadership in driving sustainable
healthcare made them a natural partner to help audit our emissions
and develop a roadmap for the future.”
Part of an existing 15-year strategic managed services agreement
between Heart Hospital and Philips, the analysis involved a
detailed lifecycle assessment of the hospital’s medical equipment,
supply chain, and clinical operations. The analysis provided a
baseline carbon footprint for Tampere Heart Hospital’s
interventional cardiology service and facilitated the
identification of opportunities to enhance patient throughput and
equipment utilization to reduce future emissions. Top findings
included optimization of the hospital’s patient care pathways to
improve efficiency and materials use, and opportunities for
reducing inbound airfreight, reducing waste and improving waste
separation.
“At Philips, we are committed to driving systemic change towards
more sustainable and equitable patient care. Through our healthcare
technology and expertise, we can help healthcare providers to
support their patients with as little impact on the environment as
possible,” said Robert Metzke, Global Head of Sustainability at
Philips. “This valuable and informative analysis with Tampere Heart
Hospital, a pioneering and leading global cardiac care provider,
will help achieve our shared goal of taking care of patients and
the planet at the same time.”
In addition to a detailed analysis of carbon emissions
associated with the hospital’s medical equipment and supply chain,
Philips’ analysis of the hospital’s current emissions also
encompasses clinical operations in key patient care pathways.
This sustainability program with Tampere Heart Hospital follows
similar analyses conducted by Philips earlier in 2023 at Vanderbilt
University Medical Center (Nashville, USA) and the private
biomedical research and clinical care provider Champalimaud
Foundation (Lisbon, Portugal), aimed at reducing the carbon
footprint of their diagnostic imaging.
Globally, healthcare systems have a significant climate
footprint and make a major contribution to the climate crisis [1].
Building on decades of experience reducing energy consumption,
waste, and materials and substance usage, Philips has operated
globally carbon-neutral since 2020, embedding EcoDesign principles
and circular business models into its innovation processes and ways
of working. The company offers a range of health technologies and
innovations that help reduce healthcare providers’ impact on the
environment. For example, its Philips Spectral CT 7500 uses 62.5%
less energy [2], and the Philips MR – Ingenia Ambition 1.5T, which
uses a breakthrough design where the magnetic components are
completely sealed and only need seven liters of helium over its
lifetime compared to roughly 1,500 liters with other Philips
systems [3]. Additionally, with Philips MR SmartSpeed, the
Ingenia Ambition 1.5T uses up to 53% less power per patient scan
[3].
Read more here on how Philips is partnering with hospitals
around the world to drive sustainable healthcare.
[1]
https://noharm-global.org/sites/default/files/documents-files/5961/HealthCaresClimateFootprint_092319.pdf[2]
When compared to an equivalent CT model of one of the industry
leaders[3] Applicable to Ambition S. Philips SmartSpeed power
consumption versus Philips SENSE based scanning. Based on COCIR and
in-house simulated environment. Results can vary based on site
conditions.
For further information, please contact:
Joost Maltha Philips Global Press Office Tel:
+31 6 10 55
8116 Email: joost.maltha@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being through meaningful innovation. Philips’ patient- and
people-centric innovation leverages advanced technology and deep
clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in
diagnostic imaging, ultrasound, image-guided therapy, monitoring
and enterprise informatics, as well as in personal health. Philips
generated 2022 sales of EUR 17.8 billion and employs approximately
71,500 employees with sales and services in more than 100
countries. News about Philips can be found at
www.philips.com/newscenter.
- Tampere Heart Hospital Finland
Koninklijke Philips NV (EU:PHIA)
過去 株価チャート
から 4 2024 まで 5 2024
Koninklijke Philips NV (EU:PHIA)
過去 株価チャート
から 5 2023 まで 5 2024